12th International Bordetella Symposium

第十二届国际博德特氏菌研讨会

• 批准号: 9805872
• 负责人: Eric T Harvill
• 金额: $ 3万
• 依托单位: UNIVERSITY OF GEORGIA
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-12-01 至 2019-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9805872
• 关键词: 12th; International; Bordetella; Symposium

Project Summary/Abstract: Pertussis or whooping cough was once considered a disease of the past but it is now one of the least controlled vaccine preventable diseases. Pertussis is primarily caused by the Gram negative pathogen, Bordetella pertussis, but several other Bordetellae cause similar diseases in humans as well as animals. The reemergence of pertussis correlates with the transition to the acellular pertussis vaccines (DTaP and Tdap) in the early 1990s. Since the 1960’s the Bordetella research community has organized international meetings which provide an opportunity for trainees, physicians, scientists, epidemiologists, public health officials, and vaccine manufacturers to assemble and focus on the problems together to move forward. The International Symposium occurs on a three-four year cycle. The International Bordetella Symposium has served to build collaborations, exchange ideas, establish priorities, and facilitate training opportunities for the next generation of scientists. At the 11th symposium there were 50 oral presentations and 110 posters presented by 196 attendees from 20 total countries. The 12th Symposium will be held at Brussels University and will be hosted by Prof. Françoise Mascart and Dr. Camille Locht. The organizing committee made up of 11 internationally known scientists who will directly participate in the planning and administration of meeting. It is expected the 12th symposium will host 300 participants. The meeting agenda includes: Bordetella biology, genomics, evolution, epidemiology, pathogenesis and virulence factors, animal models of disease and transmission, immune responses to infection and immunization, vaccine design, as well as other important topics. While there are numerous meetings that discuss bacterial pathogens, this is the only symposium that exclusively focuses on Bordetella. In order to support development of the next generation of scientists, this application is requesting funds to defray the costs of the 12th International Bordetella Symposium, in Brussels in April 2019.

项目摘要/摘要：百日咳或百日咳曾经被认为是一种疾病， 过去，它是最不受控制的疫苗可预防疾病之一。百日咳是 主要由革兰氏阴性病原体百日咳博德特氏菌引起，但其他几种 博德特氏菌在人类和动物中引起类似的疾病。重新出现 百日咳与无细胞百日咳疫苗（DTaP和Tdap）的过渡有关， 90年代初。自20世纪60年代以来，博德特氏菌研究团体组织了 国际会议为受训人员、医生、科学家 流行病学家、公共卫生官员和疫苗制造商聚集在一起， 一起解决问题，共同前进。国际研讨会将于3月4日举行。 年周期。国际博德特氏菌研讨会有助于建立合作， 交流思想，确定优先事项，为下一代提供培训机会 科学家们。在第11届研讨会上，有50个口头报告和110张海报 共有来自20个国家的196名与会者出席。第十二届研讨会将于 会议将在布鲁塞尔大学举行，由Françoise Mascart教授和Camille Locht博士主持。的 组委会由11位国际知名科学家组成，他们将直接参与 会议的规划和管理。预计第12届研讨会将举办300场 参与者会议议程包括：博德特氏菌生物学，基因组学，进化， 流行病学、发病机理和毒力因子、疾病和传播的动物模型， 对感染和免疫的免疫反应、疫苗设计以及其他重要的 话题虽然有许多会议讨论细菌病原体，但这是唯一的 专门讨论博德特氏菌的研讨会。为了支持未来的发展， 一代科学家，这个应用程序是要求资金支付的费用， 2019年4月在布鲁塞尔举行的第12届国际博德特氏菌研讨会。